Evidence map›Paper›PMID 41031008›Full record

ArticlebioRxiv : the preprint server for biology2025

Improved Injury Detection Through Harmonizing Multi-Site Neuroimaging Data after Experimental TBI: A Translational Outcomes Project in NeuroTrauma (TOP-NT) Consortium Study.

G Kislik, R Fox, A V Korotcov, J Zhou, M Febo, Babak Moghadas, Adnan Bibic, Yunfan Zou, Jieru Wan, R C Koehler and 10 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

G KislikUCLA Brain Injury Research Center, Department of Neurosurgery, Geffen Medical School.
R FoxUCLA Brain Injury Research Center, Department of Neurosurgery, Geffen Medical School.
A V KorotcovDepartment of Radiology & Bioengineering, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
J ZhouDepartment of Radiology, Johns Hopkins University, Baltimore, Maryland, USA.
M FeboDepartment of Psychiatry, University of Florida, Gainesville, Florida, USA.ORCID 0000-0001-8981-4163
Babak MoghadasDepartment of Radiology, Johns Hopkins University, Baltimore, Maryland, USA.
Adnan BibicDepartment of Radiology, Johns Hopkins University, Baltimore, Maryland, USA.
Yunfan ZouDepartment of Radiology, Johns Hopkins University, Baltimore, Maryland, USA.
Jieru WanDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
R C KoehlerDepartment of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
T AdebayoDepartment of Radiology & Bioengineering, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
M P BurnsDepartment of Neuroscience, Georgetown University Medical Center, Washington, DC, USA.
J T McCabeDepartment of Anatomy, Physiology & Genetics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
K K WangMorehouse School of Medicine, Atlanta, Georgia, USA.
J R HuieUniversity of California San Francisco, San Francisco, California, USA.
A R FergusonUniversity of California San Francisco, San Francisco, California, USA.
A PaydarUCLA Brain Injury Research Center, Department of Neurosurgery, Geffen Medical School.
I B WannerIntellectual Development and Disabilities Research Center, University of California at Los Angeles, Los Angeles, CA, 90095, USA.
N G HarrisUCLA Brain Injury Research Center, Department of Neurosurgery, Geffen Medical School.ORCID 0000-0002-1965-6750
TOP-NT Investigators

Funding

Predictive Accuracy of Acute Astroglial Compromise Biomarkers after Traumatic Brain InjuryUH3NS106945 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HARRIS, NEIL, WANNER, INA BEATE · 2020 to 2023
$1.4M
Development of Novel Functional Markers for TBI Using Molecular MRIUH3NS106937 · NINDS · JOHNS HOPKINS UNIVERSITY · PI KOEHLER, RAYMOND CHARLES, ZHOU, JINYUAN · 2020 to 2022
$1.3M
Detecting the disruption and recovery of synaptic connectivity after TBIUH3NS106941 · NINDS · GEORGETOWN UNIVERSITY · PI BURNS, MARK P · 2020 to 2022
$1.2M
Translational Outcomes Project: Visualizing Syndromic Information and Outcomes for Neurotrauma (TOP-VISION)UH3NS106899 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BEATTIE, MICHAEL S, BRESNAHAN, JACQUELINE C · 2020 to 2022
$1.2M
NIBA-TBI: Neuro-Imaging and biofluid-based Biomarker Assessments as translational pathophysiological outcome measures in TBIUH3NS106938 · NINDS · UNIVERSITY OF FLORIDA · PI WANG, KEVIN KA WANG · 2020 to 2023
$1.1M
Predictive accuracy of acute astroglial compromise biomarkers after traumatic brain injuryUG3NS106945 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HARRIS, NEIL, WANNER, INA BEATE · 2018 to 2020
$882k
Development of Novel Functional Markers for TBI Using Molecular MRIUG3NS106937 · NINDS · JOHNS HOPKINS UNIVERSITY · PI KOEHLER, RAYMOND CHARLES, ZHOU, JINYUAN · 2018 to 2019
$859k
NIBA-TBI: Neuro-Imaging and biofluid-based Biomarker Assessments as translational pathophysiological outcome measures in TBIUG3NS106938 · NINDS · UNIVERSITY OF FLORIDA · PI WANG, KEVIN KA WANG · 2018 to 2019
$758k
Detecting the disruption and recovery of synaptic connectivity after TBIUG3NS106941 · NINDS · GEORGETOWN UNIVERSITY · PI BURNS, MARK P · 2018 to 2019
$750k
Translational Outcomes Project: Visualizing Syndromic Information and Outcomes for Neurotrauma (TOP-VISION)UG3NS106899 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BEATTIE, MICHAEL S, BRESNAHAN, JACQUELINE C · 2018 to 2019
$480k
NINDS NIH HHS UG3 NS106899NINDS NIH HHS UG3 NS106937NINDS NIH HHS UG3 NS106938NINDS NIH HHS UG3 NS106941NINDS NIH HHS UG3 NS106945NINDS NIH HHS UH3 NS106899NINDS NIH HHS UH3 NS106937NINDS NIH HHS UH3 NS106938NINDS NIH HHS UH3 NS106941NINDS NIH HHS UH3 NS106945
6 · The paper itself

Abstract

Multi-site neuroimaging studies have become increasingly common in order to generate larger samples of reproducible data to answer questions associated with smaller effect sizes. The data harmonization model NeuroCombat has been shown to remove site effects introduced by differences in site-related technical variance while maintaining group differences, yet its effect on improving statistical power in pre-clinical models of CNS disease is unclear. The present study examined fractional anisotropy data computed from diffusion weighted imaging data at 3 and 30 days post-controlled cortical impact injury from 184 adult rats across four sites as part of the Translational-Outcome-Project-in-Neurotrauma (TOP-NT) Consortium. Findings confirmed prior clinical reports that NeuroCombat fails to remove site effects in data containing a high proportion-of-outliers (>5%) and skewness, which introduced significant variation in non-outlier sites. After removal of one outlier site and harmonization using a global sham population, harmonization displayed an increase in effect size in data that displayed group level effects (p<0.01) in both univariate and voxel-level volumes of pathology. This was characterized by movement toward similar distributions in voxel measurements (Kolmogorov-Smirnov p<<0.001 to >0.01) and statistical power increases within the ipsilateral cortex. Harmonization improved statistical power and frequency of significant differences in areas with existing group differences, thus improving the ability to detect regions affected by injury rather than by other confounds. These findings indicate the utility of NeuroCombat in reproducible data collection, where biological differences can be accurately revealed to allow for greater reliability in multi-site neuroimaging studies.

Indexed as

controlled cortical impact injuryDiffusion-weighted imagingharmonizationmulti-siteTraumatic Brain Injury

Identifiers

PMID41031008
PMCPMC12478386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.